Navigation überspringen
Universitätsbibliothek Heidelberg
Standort: ---
Exemplare: ---
heiBIB
 Online-Ressource
Verfasst von:Klinke, Glynis [VerfasserIn]   i
 Richter, Sylvia [VerfasserIn]   i
 Monostori, Péter [VerfasserIn]   i
 Schmidt‐Mader, Brigitte [VerfasserIn]   i
 García‐Cazorla, Angels [VerfasserIn]   i
 Artuch, Rafael [VerfasserIn]   i
 Christ, Stine [VerfasserIn]   i
 Opladen, Thomas [VerfasserIn]   i
 Hoffmann, Georg F. [VerfasserIn]   i
 Blau, Nenad [VerfasserIn]   i
 Okun, Jürgen G. [VerfasserIn]   i
Titel:Targeted cerebrospinal fluid analysis for inborn errors of metabolism on an LC-MS/MS analysis platform
Verf.angabe:Glynis Klinke, Sylvia Richter, Péter Monostori, Brigitte Schmidt‐Mader, Angels García‐Cazorla, Rafael Artuch, Stine Christ, Thomas Opladen, Georg F. Hoffmann, Nenad Blau, Jürgen G. Okun
E-Jahr:2020
Jahr:13 January 2020
Umfang:14 S.
Fussnoten:Gesehen am 13.10.2020
Titel Quelle:Enthalten in: Journal of inherited metabolic disease
Ort Quelle:Hoboken, NJ : Wiley, 1978
Jahr Quelle:2020
Band/Heft Quelle:43(2020), 4, Seite 712-725
ISSN Quelle:1573-2665
Abstract:Background Laboratory investigations of cerebrospinal fluid (CSF) are essential when suspecting an inborn error of metabolism (IEM) involving neurological features. Available tests are currently performed on different analytical platforms, requiring a large sample volume and long turnaround time, which often delays timely diagnosis. Therefore, it would be preferable to have an “one-instrument” targeted multi-metabolite approach. Method A liquid chromatography-tandem mass spectrometry (LC-MS/MS) platform, based on two different methods for analysing 38 metabolites using positive and negative electrospray ionisation modes, was established. To allow for platform extension, both methods were designed to use the same CSF sample preparation procedure and to be run on the same separation column (ACE C18-PFP). Results Assessment of the LC-MS/MS platform methods was first made by analytical validation, followed by the establishment of literature-based CSF cut-off values and reference ranges, and by the measurement of available samples obtained from patients with confirmed diagnoses of aromatic l-amino acid decarboxylase deficiency, guanidinoacetate methyltransferase deficiency, ornithine aminotransferase deficiency, cerebral folate deficiency and methylenetetrahydrofolate reductase deficiency. Conclusion An extendable targeted LC-MS/MS platform was developed for the analysis of multiple metabolites in CSF, thereby distinguishing samples from patients with IEM from non-IEM samples. Reference concentrations for several biomarkers in CSF are provided for the first time. By measurement on a single analytical platform, less sample volume is required (200 μL), diagnostic results are obtained faster, and preanalytical issues are reduced. Synopsis LC-MS/MS platform for CSF analysis consisting of two differentially designed methods.
DOI:doi:10.1002/jimd.12213
URL:Volltext: https://doi.org/10.1002/jimd.12213
 Volltext: https://onlinelibrary.wiley.com/doi/abs/10.1002/jimd.12213
 DOI: https://doi.org/10.1002/jimd.12213
Datenträger:Online-Ressource
Sprache:eng
Sach-SW:cerebrospinal fluid
 inborn errors of metabolism
 inherited metabolic diseases
 liquid chromatography coupled to tandem mass spectrometry
 reference ranges
 targeted metabolomics
K10plus-PPN:173548184X
Verknüpfungen:→ Zeitschrift
 
 
Lokale URL UB: Zum Volltext

Permanenter Link auf diesen Titel (bookmarkfähig):  https://katalog.ub.uni-heidelberg.de/titel/68647966   QR-Code
zum Seitenanfang